Cas No.: | 2173153-38-1 |
Chemical Name: | (S)-3-((1-methoxybutan-2-yl)oxy)-5-((6-(methylsulfonyl)pyridin-3-yl)methyl)-N-(4-((2-oxido-1,3,2-dioxaphosphinan-2-yl)methyl)thiazol-2-yl)benzamide |
Synonyms: | BMS-212,BMS212,BMS 212 |
SMILES: | C(NC1=NC(CP(=O)2OCCCO2)=CS1)(=O)C1=CC(CC2=CC=C(S(C)(=O)=O)N=C2)=CC(O[C@H](CC)COC)=C1 |
Formula: | C25H30N3O9PS2 |
M.Wt: | 611.621 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | BMS-212 is a potent and selective stimulator of glucokinase (GK) (EC50 = 35 nM) that is promisingly used as an antidiabetic. BMS-212 has a preference for GK in liver over GK in pancreas, of which the activation may lead to non-glucose-dependent insulin secretion. Half-life of BMS-212 is 4.2h, and oral bioavailability is 15%. |